ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy

The deoxyribonucleic acid (DNA) repair gene encoding the excision-repair cross-complementation group 1 (ERCC1) protein is known to predict the response to platinum-based chemotherapy. Our aim was to explore whether ERCC1 expression predicted tumor response and survival in patients with recurrent or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Hyewon, Song, Ik-Chan, Choi, Yoon-Seok, Yun, Hwan-Jung, Jo, Deog-Yeon, Kim, Jin Man, Ko, Young Bok, Lee, Hyo Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758255/
https://www.ncbi.nlm.nih.gov/pubmed/29390553
http://dx.doi.org/10.1097/MD.0000000000009402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758255/
https://www.ncbi.nlm.nih.gov/pubmed/29390553
http://dx.doi.org/10.1097/MD.0000000000009402

Ejemplares similares